Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Chinese Subjects With Severe Alzheimer's Disease
NCT01404169Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Sep 2011; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01404169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404169.